Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic Inc (NQ: HOLX )

82.33 +1.46 (+1.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,955,998
Open 80.99
Bid (Size) 82.00 (2)
Ask (Size) 82.33 (2)
Prev. Close 80.87
Today's Range 80.86 - 83.05
52wk Range 66.93 - 84.49
Shares Outstanding 253,487,389
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally... 
Via Benzinga

Performance

YTD
+13.62%
+13.62%
1 Month
+3.93%
+3.93%
3 Month
-0.04%
-0.04%
6 Month
+8.43%
+8.43%
1 Year
+19.89%
+19.89%

More News

Read More
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Assessing Hologic: Insights From 10 Financial Analysts
Via Benzinga
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
From Hologic, Inc.
Via Business Wire
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Hologic, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years
Via Benzinga
Analyst Scoreboard: 8 Ratings For Hologic
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today
Via Benzinga
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Hologic Analysts Boost Their Forecasts After Q3 Results
Via Benzinga
The Analyst Verdict: Hologic In The Eyes Of 8 Experts
Via Benzinga
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
Via Benzinga
GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Hologic Announces Financial Results for Third Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
Via Benzinga
Hologic Completes Acquisition of Endomagnetics Ltd
From Hologic, Inc.
Via Business Wire
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation
Via News Direct
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.